Form 8-K - Current report:
SEC Accession No. 0001595585-21-000107
Filing Date
2021-08-16
Accepted
2021-08-16 16:51:46
Documents
13
Period of Report
2021-08-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcda-20210812.htm   iXBRL 8-K 37021
5 GRAPHIC tcda-20210812_g1.jpg GRAPHIC 5018
  Complete submission text file 0001595585-21-000107.txt   191543

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20210812.xsd EX-101.SCH 1924
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20210812_lab.xml EX-101.LAB 25293
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20210812_pre.xml EX-101.PRE 13200
6 EXTRACTED XBRL INSTANCE DOCUMENT tcda-20210812_htm.xml XML 11265
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38558 | Film No.: 211179306
SIC: 2834 Pharmaceutical Preparations